发明名称 |
Urinary biomarkers in HIV infected subjects |
摘要 |
<p>The present invention relates to the field of diagnostic measures. Specifically, it is directed to a method for assessing whether an HIV infected subject who is or who will be administered a nucleotide reverse transcriptase inhibitor is susceptible to the administration of a non-nucleoside reverse transcriptase inhibitor (NNRTI), said method comprising determining the amount of L-FABP (liver fatty acid binding protein) in a sample from said subject, and comparing the amount of L-FABP to a reference amount, whereby it is assessed whether said subject is susceptible to the administration of a non-nucleoside reverse transcriptase inhibitor (NNRTI). Further encompassed are diagnostic devices and kits for carrying out the aforementioned methods.</p> |
申请公布号 |
EP2392926(A1) |
申请公布日期 |
2011.12.07 |
申请号 |
EP20110153906 |
申请日期 |
2011.02.09 |
申请人 |
ROCHE DIAGNOSTICS GMBH;F. HOFFMANN-LA ROCHE AG |
发明人 |
HESS, GEORG;HORSCH, ANDREAS;ZDUNEK, DIETMAR |
分类号 |
G01N33/68 |
主分类号 |
G01N33/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|